Comprehensive cardiovascular risk factor control improves survival: The BARI 2D trial

Journal of the American College of Cardiology

Volumn 66, Issue 7, 2015, Pages 765-773

  Bittner, Vera ^a   Bertolet, Marnie ^b   Barraza Felix, Rafael ^c   Farkouh, Michael E ^d   Goldberg, Suzanne ^e   Ramanathan, Kodangudi B ^f   Redmon, J Bruce ^g   Sperling, Laurence ^h   Rutter, Martin K ^i,j  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

blood pressure; cholesterol; coronary heart disease; diabetes mellitus; glycosylated hemoglobin A; smoking

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SMOKING; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TRENDS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL RATE;

EID: 84939526817     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.06.019     Document Type: Article

References (14)

1. E.S. Ford, U.A. Ajani, J.B. Croft, and et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398
2. A.S. Go, D. Mozaffarian, V.L. Roger, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
3. S. Stark Casagrande, J.E. Fradkin, S.H. Saydah, and et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010 Diabetes Care 36 2013 2271 2279
4. P. Gaede, P. Vedel, N. Larsen, and et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393
5. P. Gaede, H. Lund-Andersen, H.H. Parving, and et al. Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591
6. M.M. Brooks, R.L. Frye, S. Genuth, et al. for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol 97 2006 9G 19G
7. BARI 2D Study Group R.L. Frye, P. August, and et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
8. J. Albu, S.H. Gottlieb, P. August, et al. for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators Modifications of coronary risk factors Am J Cardiol 97 2006 41G 52G
9. ACCORD Study Group H.C. Gerstein, M.E. Miller, and et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes N Engl J Med 364 2011 818 828
10. J.I. Barzilay, A.G. Howard, G.W. Evans, and et al. Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial Diabetes Care 35 2012 1401 1405
11. W.E. Boden, R.A. O'Rourke, K.K. Teo, et al. for the COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
12. M.E. Farkouh, M. Domanski, L.A. Sleeper, et al. for the FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
13. B.V. Howard, M.J. Roman, R.B. Devereux, and et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial JAMA 299 2008 1678 1689
14. R.M. Cooper-DeHoff, Y. Gong, E.M. Handberg, and et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease JAMA 304 2010 61 68